Cline Scientific AB (OSTO:CLINE B) Other Stockholders Equity: kr17.23 Mil (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:CLINE B Cline Scientific AB OSTO:CLINE B
4 GF Score
Price kr0.07
View Full Analysis

What is Cline Scientific AB Other Stockholders Equity?

Cline Scientific AB OSTO:CLINE B 4 Other Stockholders Equity is kr17.23 Mil as of Dec. 2023. GuruFocus rates OSTO:CLINE B with a GF Score™ of 4/100.

Cline Scientific AB's Other Stockholders Equity for the quarter that ended in Dec. 2023 was kr17.23 Mil.

Cline Scientific AB's quarterly Other Stockholders Equity increased from Dec. 2022 (kr13.03 Mil) to Jun. 2023 (kr13.03 Mil) and increased from Jun. 2023 (kr13.03 Mil) to Dec. 2023 (kr17.23 Mil).

Cline Scientific AB's annual Other Stockholders Equity increased from Dec. 2021 (kr10.14 Mil) to Dec. 2022 (kr13.03 Mil) and increased from Dec. 2022 (kr13.03 Mil) to Dec. 2023 (kr17.23 Mil).

Cline Scientific AB Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cline Scientific AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cline Scientific AB Other Stockholders Equity Chart

Cline Scientific AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.13 6.53 10.14 13.03 17.23

Cline Scientific AB Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.14 10.14 13.03 13.03 17.23
OSTO:CLINE B
4GF Score
Cline Scientific AB OSTO:CLINE B
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cline Scientific AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of kr17.23 Mil mean?
Cline Scientific AB (OSTO:CLINE B) has a Other Stockholders Equity of kr17.23 Mil as of Dec. 2023. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cline Scientific AB and its competitors.
Is Cline Scientific AB's Other Stockholders Equity too high?
Cline Scientific AB's current Other Stockholders Equity is kr17.23 Mil. Overall, Cline Scientific AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Cline Scientific AB's Other Stockholders Equity compare to VRTX and REGN?
Cline Scientific AB's Other Stockholders Equity of kr17.23 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cline Scientific AB and its competitors. Cline Scientific AB's current Other Stockholders Equity is kr17.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cline Scientific AB stock overvalued right now?
Cline Scientific AB (OSTO:CLINE B) has a current Other Stockholders Equity of kr17.23 Mil. The current Other Stockholders Equity is kr17.23 Mil. Cline Scientific AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Cline Scientific AB (OSTO:CLINE B), the current Other Stockholders Equity is kr17.23 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cline Scientific AB Business Description

Address Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153
Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.
4GF Score

Get the complete analysis for OSTO:CLINE B

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.07
Price